Position in ROIV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,036,219
+$660,896 QoQ
Shares Held
29,280
+69.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#234
of 494 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $122,705,584 across 67 Biotechnology names. ROIV ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,614 | $45,507,422 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,220 | $17,596,298 | |
| 3 | INCY |
Incyte Corp
|
104,901 | $11,891,577 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,327 | $8,828,306 | |
| 5 | RPRX |
Royalty Pharma plc
|
136,283 | $7,641,386 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,736 | $3,321,598 | |
| 7 | INSM |
INSMED Inc
|
27,552 | $2,937,594 | |
| 8 | MRNA |
Moderna, Inc.
|
25,088 | $1,756,912 |
All Filings in ROIV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,036,219 | 29,280 | Shares | Sole | 2026-07-29 | |
| 2025-12-31 | $375,323 | 17,296 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $217,493 | 14,375 | Shares | Sole | 2025-12-02 | |
| No filing history on record for this holder in this stock. | ||||||